Oaktree Specialty Lending (OCSL) Earnings Analysis
Oaktree Specialty Lending (OCSL) has no confirmed upcoming earnings date. Last quarter (2026-02-04) it beat with EPS 0.41 USD vs 0.38 USD est (+7.9%). It has beaten estimates in 3/6 recent quarters (50%). Trailing P/E 20.66.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does OCSL next report earnings?
No confirmed upcoming earnings date is currently scheduled for OCSL. This page updates as the calendar is published.
OCSL earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-02-04 | 0.41 USD | 0.38 USD | +7.9% | Beat |
| 2025-11-18 | 0.4 USD | 0.3861 USD | +3.6% | Beat |
| 2025-05-01 | 0.45 USD | 0.51 USD | -11.8% | Miss |
| 2025-02-04 | 0.54 USD | 0.54 USD | 0% | Beat |
| 2024-11-19 | 0.55 USD | 0.56 USD | -1.8% | Miss |
| 2024-08-01 | 0.55 USD | 0.57 USD | -3.5% | Miss |
Beat rate: 3/6 (50%) over reported quarters with consensus data.
OCSL valuation and analyst view
| Trailing P/E | 20.66 |
|---|---|
| Trailing EPS | 0.56364 USD |
| Price / book | 0.76 |
| Dividend yield | 13.00% |
| Market cap | 1.04B |
| Analyst consensus | Hold (5 buy / 7 hold / 0 sell) |
| Avg price target | 13 USD |
Related research pages
Frequently asked questions
When is Oaktree Specialty Lending (OCSL)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for OCSL. This page updates as the calendar is published.
Did OCSL beat earnings last quarter?
In its 2026-02-04 report, OCSL posted EPS of 0.41 USD versus a 0.38 USD estimate — a beat of 7.9%.
What is OCSL's earnings track record?
Over the last 6 reported quarters with consensus data, OCSL beat estimates 3 times (50%).
What is OCSL's current P/E ratio and EPS?
OCSL trades at a trailing P/E of 20.66 on trailing EPS of 0.5636423495220579 USD.
What do analysts rate OCSL?
Analyst consensus is "Hold" across 12 ratings (0 strong buy, 5 buy, 7 hold, 0 sell, 0 strong sell). Average 12-month price target: 13 USD.